Cargando…
Magnetic, biocompatible FeCO(3) nanoparticles for T2-weighted magnetic resonance imaging of in vivo lung tumors
BACKGROUND: Late diagnosis of lung cancer is one of the leading causes of higher mortality in lung cancer patients worldwide. Significant research attention has focused on the use of magnetic resonance imaging (MRI) based nano contrast agents to efficiently locate cancer tumors for surgical removal...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8952886/ https://www.ncbi.nlm.nih.gov/pubmed/35337331 http://dx.doi.org/10.1186/s12951-022-01355-3 |